Hilfe beim Zugang

Haben Sie den VPN-Client gestartet bzw. sind Sie via Shibboleth angemeldet (weitere Informationen)?

In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models

Background Dendritic cells (DCs) are a promising therapeutic target in cancer immunotherapy given their ability to prime antigen-specific T cells, and initiate antitumor immune response. A major obstacle for DC-based immunotherapy is the difficulty to obtain a sufficient number of functional DCs. Th...
Ausführliche Beschreibung